en services capabilities practices capital-markets-transactions 
Physics World
MAY 30, 2021
According to speakers at the inaugural Quantum West conference, the transition from lab-based R&D towards market-ready solutions is already under way. Well, there are already some quantum instruments that are in service now. Applications for quantum sensors are also emerging.
Arnold Porter
JUNE 2, 2021
In the mid-2000s, GSK and Teva settled a patent dispute brought by GSK after Teva sought to market a generic version of Lamictal before GSK's patent expired using the Hatch-Waxman Act procedures. The district court also dismissed the Section 1 market allocation and "pay-for-delay" claims. [[N:Complaint, Louisiana Wholesale Drug Co.,
Expert insights. Personalized for you.
137 
Let's personalize your content